GENE ONLINE|News &
Opinion
Blog

Renal Cell Carcinoma
Merck, Eisai’s Keytruda-Lenvima Combo Fails in Melanoma and Colorectal Cancer Trials
2023-04-10
Merck Regains Worldwide Rights to BAVENCIO After Parting Ways with Pfizer
2023-03-29
Merck’s Keytruda Bags FDA Approval for Early Kidney Cancer in Adjuvant Setting
2021-11-18
AVEO Oncology Rejoices FDA Approval for TKI, Finds Able Partner in BMS to Trial Combo Therapy for Kidney Cancer
2021-03-13
Merck, Eisai’s Combo Therapy Registers Superiority against Pfizer’s Drug in Kidney Cancer Trial
2020-11-15
FDA Accepts Opdivo, Cabometyx Combo’s Priority Review Applications
2020-10-21
Korean Firm, Asia’s First to Get FDA Clearance for Testing Anti-Cancer Microbiome Therapeutic
2020-04-24
LATEST
Biotech Sector Updates: Reports Cover Research Advances and Industry Events
2025-05-14
GSK Adds Efimosfermin to Hepatology Portfolio, Citing Novel Mechanism of Action for Liver Disease Treatment
2025-05-14
New Generic Drug Impacts Oncology and Community Pharmacists.
2025-05-14
Novo Nordisk and Septerna Partner to Develop Oral Obesity Medications
2025-05-14
Ixchiq Vaccine Adverse Event Investigations Focus on Elderly Recipients
2025-05-14
Liver Disease Treatment Investment Resurges Amid Growing Unmet Needs
2025-05-14
Gene and Cell Therapies in Focus at ASGCT 2025: Tackling Rare Diseases, Autoimmune Conditions, and More
2025-05-14
EVENT
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top